BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garrett MR, Korstanje R. Using Genetic and Species Diversity to Tackle Kidney Disease. Trends Genet 2020;36:499-509. [PMID: 32362446 DOI: 10.1016/j.tig.2020.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Röck R, Rizzo L, Lienkamp SS. Kidney development - recent insights from technological advances. Physiology. [DOI: 10.1152/physiol.00041.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ruchika, Sharma A, Saneja A. Zebrafish as a powerful alternative model organism for preclinical investigation of nanomedicines. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lei Y, Anders H. Preclinical Randomized Controlled Trials in Nephrology. Innovations in Nephrology 2022. [DOI: 10.1007/978-3-031-11570-7_27] [Reference Citation Analysis]
4 Khan K, Ahram DF, Liu YP, Westland R, Sampogna RV, Katsanis N, Davis EE, Sanna-Cherchi S. Multidisciplinary approaches for elucidating genetics and molecular pathogenesis of urinary tract malformations. Kidney Int 2021:S0085-2538(21)01060-7. [PMID: 34780871 DOI: 10.1016/j.kint.2021.09.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Arroyo J, Escobar-Zarate D, Wells HH, Constans MM, Thao K, Smith JM, Sieben CJ, Martell MR, Kline TL, Irazabal MV, Torres VE, Hopp K, Harris PC. The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1RC/RC mouse model of autosomal dominant polycystic kidney disease. Kidney Int 2021;99:1392-407. [PMID: 33705824 DOI: 10.1016/j.kint.2021.01.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]